No Data
Shanghai Labway Clinical Laboratory Co., Ltd (SZSE:301060) Investors Are Less Pessimistic Than Expected
Lanwei Medical (301060.SZ) issued a warning of a pre-loss, expecting a net loss of 0.107 billion yuan to 0.157 billion yuan for the year 2024.
Lanwei Medical (301060.SZ) released its performance forecast for 2024, expecting the full-year results to be attributable to the listed company Shareholder...
Lanwei Medical: 2024 Annual Results Forecast
Shanghai Labway Clinical Laboratory Co., Ltd's (SZSE:301060) Stock Price Dropped 8.8% Last Week; Private Companies Would Not Be Happy
Lanwei Medical (301060.SZ): Zeng Weixiong was elected as the company's Director.
Gelonghui, December 16 - Lanwei Medical (301060.SZ) announced that, after being reviewed and approved by the Board of Directors, Mr. Zeng Weixiong was elected as the chairman of the company, with a term starting from the date of approval at the first meeting of the fourth Board of Directors until the end of the fourth Board of Directors' term.
Lan Wei Medical (301060.SZ): Hailan Group has cumulatively reduced its shareholding by 5%.
Lanwei Medical (301060.SZ) announced that shareholder Hailan Group Co., Ltd. (referred to as "Hailan Group") from...
Investors Give Shanghai Labway Clinical Laboratory Co., Ltd (SZSE:301060) Shares A 27% Hiding